Jaguar Health Inc (JAGX)
0.259
-0.03
(-9.66%)
USD |
NASDAQ |
May 17, 16:00
0.127
-0.13
(-50.97%)
After-Hours: 20:00
Jaguar Health Research and Development Expense (Quarterly): 4.312M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 4.312M |
| December 31, 2023 | 3.463M |
| September 30, 2023 | 6.081M |
| June 30, 2023 | 4.277M |
| March 31, 2023 | 4.775M |
| December 31, 2022 | 4.311M |
| September 30, 2022 | 5.94M |
| June 30, 2022 | 2.451M |
| March 31, 2022 | 4.945M |
| December 31, 2021 | 5.482M |
| September 30, 2021 | 3.312M |
| June 30, 2021 | 3.87M |
| March 31, 2021 | 2.414M |
| December 31, 2020 | 1.904M |
| September 30, 2020 | 1.522M |
| June 30, 2020 | 1.405M |
| March 31, 2020 | 1.582M |
| December 31, 2019 | 1.394M |
| September 30, 2019 | 1.307M |
| June 30, 2019 | 1.698M |
| March 31, 2019 | 1.421M |
| Date | Value |
|---|---|
| December 31, 2018 | 1.311M |
| September 30, 2018 | 1.481M |
| June 30, 2018 | 1.605M |
| March 31, 2018 | 0.7579M |
| December 31, 2017 | 1.236M |
| September 30, 2017 | 0.8516M |
| June 30, 2017 | 0.9268M |
| March 31, 2017 | 1.256M |
| December 31, 2016 | 1.534M |
| September 30, 2016 | 1.967M |
| June 30, 2016 | 1.954M |
| March 31, 2016 | 1.752M |
| December 31, 2015 | 2.062M |
| September 30, 2015 | 1.240M |
| June 30, 2015 | 1.751M |
| March 31, 2015 | 1.423M |
| December 31, 2014 | 0.9443M |
| September 30, 2014 | 1.126M |
| June 30, 2014 | 0.6912M |
| March 31, 2014 | 1.458M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
1.307M
Minimum
Sep 2019
6.081M
Maximum
Sep 2023
3.322M
Average
3.388M
Median
Research and Development Expense (Quarterly) Benchmarks
| BioSig Technologies Inc | 1.176M |
| BioVie Inc | 6.470M |
| Entero Therapeutics Inc | 1.307M |
| Genprex Inc | 3.713M |
| Adial Pharmaceuticals Inc | 0.2644M |